SARS COV-2 VARIANTS REAL TIME KIT 5 targets.
One single reaction tube per sample. Identification of the main SARS Cov-2 variants of concern, UK, South Africa, Brazil, Nigeria, Indian (Delta).
Made in Canada
Health Canada approved
CE Mark and ISO certified
The product has proven to have 100% Specificity and 96% Sensitivety
Stock availabity: 2 Million tests/kit in Canada
Production: up to 5 Million tests/kit weekly
The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only.
PRODUCT INFORMATION:
Product: Rapid Respose
Sample: Nasal / Nasopharyngeal secretions
Format: Cassette
Quantity: 25 Tests/Kit per box
Time to result: 15 minutes
Storage Condition: 2-30 C/36-86 F
Test Principle: Immunochromatographic Assay
CONTENTS - Individually packed test devices
Extraction Buffer
Extraction tube
Nozzle with filter
Tube stand
Individually packed swabs
Package Insert
5096 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.
mLab / m-screen Corona Antigen Test
Simple nasal swap* or nasopharyngeal swab** / Under 30 minutes / Sensitivity 98.32%** and 97.25%* / TCID50 115 / In stock in Germany / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / German Manufacturer / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Laihe / Novel Corona Antigen Test
Nasopharyngeal swab / under 30 minutes / Sensitivity 95.07% / CE marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute and IVD / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Nal von minden / dedico plus
Simple nasal swap or nasopharyngeal swab / under 30 minutes / Sensitivity 97.10% / TCID50 75.5 / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Joysbio Saliva Rapid Test Kit - Saliva Test Kit for public use / under 30 minutes / Sensitivity 95.10% / TCID50 320 / CE IVD marked for public use / In stock in Germany
Price 6.5 EUR + VAT
We send a POL after receiving the LOI.
We deliver in Europe only.
Only for Hospitals.
More information?
The new VivaDiag SARS-CoV-2 Ag Rapid Test is for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human nasal swab,oropharyngeal swab or nasopharyngeal swab specimen. The test is for in vitro diagnostic use only.
Special features:
For nasal or throat swab samples
CE marked
Professional Use Only
High Sensitivity
Short Turnout Time
High Specificity
Test Principle: Colloidal gold
Sample Type: Nasal swab, oropharyngeal swab or nasopharyngeal swab
Sample Volume: 60 L
Test Time: 15 min
Rapid tests available in stock in our deposits in Bucharest . Contact us to send you prices and certifications . OTG . You are welcome in our deposits to inspect our products .
Choice of nasopharyngeal swab:
The main indicators of clinical evaluation of swab performance are the absorption capacity and release capacity of the swab to the target sample at the sampling site. Nylon flocking swabs are made of fine nylon fibers adhered to a plastic rod. Compared with traditional cotton swabs, the adsorption surface is significantly larger, which is conducive to the adhesion and release of pathogenic microorganisms. The ability of nylon flocking swabs and traditional rayon cotton swabs to recover and release known microbial inoculums (spiked samples) confirms that nylon flocking swabs have the ability to release cells, microorganisms, viruses and other microorganisms Significant advantages. Compared with traditional rayon cotton, nylon flocking swabs or foam swabs have a significant advantage in the virus recovery rate in the screening of nasal cavity carrying MRSA virus.
For the choice of virus preservation solution: non-inactivated preservation solution and inactivated preservation solution.
The current test kit is based on specific antibody antigen reaction and immunoassay technique. The test card contains a gold labeled novel
coronavirus N protein monoclonal antibody p re coated on the binding pad
and a paired novel coronavirus N protein monoclonal antibodies fixed in the
test line (T) and corresponding antibodies in the quality control line (C).
During the test, the N protein in the specimen binds to the gold-labeled nove lcoronavirus N protein antibody pre-coated on the binding pad, and the
conjugate moves upward under the capillary effect, and then is trapped by N
protein monoclonal antibody conjugate fixed in the Test Line (T). The higher
the N protein content in the specimen, the more conjugates are trapped, and
the darker the color of the Test Line (T). If there is no novel coronavirus in
the specimen or the virus content is below the detection limit, no colour
appears in the Test Line (T). A purple red band will app ear in the Control
Line (C) regardless of whether there is a virus in the specimen. The
purple red band that appears in the Control Line (C) is the criteria for
determining whether there is enough specimen and whether the
chromatography process is normal.
The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C).
During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.
Super long life refrigeration sheet modified by special process;
Precision temperature control technology ensures that the temperature fluctuation of each hole is less than 0.1 ;
Ultra high sensitivity PMT system combined with precision optical system ensures accuracy;
New automatic hot cover technology can effectively prevent reagent evaporation;
Maximum 6 channels fluorescence detection, no cross interference between channels;
Intelligent operating system, flexible program setting, comprehensive analysis and report function;
Antigen Rapid Covid-19 Test Kit Medakit.
Rapid diagnosis tests for Covid-19 infections (10 minutes).
Cassette 40 test/kit.
Main compound from Germany, assembly in China.
Certifications : FDA - MOFCOM - CE - ANVISA - TGA - ISO13485 - ISP - CNR (Institut Pasteur)
5096 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.
